🔴 Connect Biopharma is trading 46.2% down in pre-market; no company-specific announcement identified

Connect Biopharma is trading 46.2% down now at $0.93 after closing at $1.73 on September 14, 2026; no new company-specific announcement was identified to explain the pre-market decline.

• Management is scheduled to present at the H.C. Wainwright conference on September 15; Phase 2 Seabreeze STAT topline results remain expected during September.
• Broader markets are only modestly lower, so macro sentiment does not clearly explain the move.